Jaffetilchin Investment Partners »

Crispr Therapeutics shares owned by Jaffetilchin Investment Partners

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Jaffetilchin Investment Partners from 13F filings

Historical chart of Jaffetilchin Investment Partners investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Jaffetilchin Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Jaffetilchin Investment Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $225k 4.9k 45.39
2023-06-30 $232k 4.1k 56.14
2022-06-30 $215k 3.5k 60.77

More positions owned by Jaffetilchin Investment Partners

Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Large Cap Etf (VV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Ishares Tr Agency Bond Etf (AGZ)
Spdr Ser Tr Portfoli S&p1500 (SPTM)

View all positions for Jaffetilchin Investment Partners

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Citadel Advisors
Vanguard Group
NEA Management Company
Caption Management
Bellevue Group
Credit Suisse
T. Rowe Price Associates
Bank of America Corporation
Dimensional Fund Advisors
Voloridge Investment Management
Ikarian Capital
Charles Schwab Investment Management

View all funds holding Crispr Therapeutics